Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Current Assets (2016 - 2025)

Medifast's Current Assets history spans 16 years, with the latest figure at $201.7 million for Q4 2025.

  • For Q4 2025, Current Assets fell 5.93% year-over-year to $201.7 million; the TTM value through Dec 2025 reached $201.7 million, down 5.93%, while the annual FY2025 figure was $201.7 million, 5.93% down from the prior year.
  • Current Assets reached $201.7 million in Q4 2025 per MED's latest filing, down from $207.8 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $324.3 million in Q1 2022 to a low of $201.7 million in Q4 2025.
  • Average Current Assets over 5 years is $241.7 million, with a median of $224.6 million recorded in 2024.
  • Peak YoY movement for Current Assets: surged 74.83% in 2021, then decreased 28.97% in 2023.
  • A 5-year view of Current Assets shows it stood at $306.9 million in 2021, then dropped by 27.4% to $222.8 million in 2022, then increased by 0.56% to $224.0 million in 2023, then fell by 4.3% to $214.4 million in 2024, then dropped by 5.93% to $201.7 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Current Assets are $201.7 million (Q4 2025), $207.8 million (Q3 2025), and $206.4 million (Q2 2025).